LivaNova PLC

Ownership Transactions Reported by 26 Insiders

Symbol
LIVN on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
20 Eastbourne Terrace, London, United Kingdom

Insiders trading volume in the past year

LivaNova PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Damien McDonald CEO, Director $14.3M Mar 30, 2023
Vladimir Makatsaria Chief Executive Officer, Director $8.4M Mar 30, 2025
Alex Shvartsburg Chief Financial Officer $3.59M Mar 30, 2025
Ahmet Tezel Chief Innovation Officer $2.48M Jun 15, 2025
Michael Damon Hutchinson Chief Legal Officer $2.32M Mar 30, 2025
Stephanie Bolton President, Global Epilepsy $2.15M Mar 30, 2025
Franco Poletti President, Cardiopulmonary $1.97M Sep 15, 2025
Daniel J. Moore Director $1.81M Jun 3, 2024
Trui Hebbelinck Chief Human Resources Officer $1.71M Mar 30, 2024
Marco Dolci President CP $1.71M Mar 30, 2023
Natalia Kozmina Chief Human Resources Officer $1.5M Mar 30, 2025
William A. Kozy Director $1.49M Jun 15, 2025
Arthur L. Rosenthal Director $1.22M Jun 15, 2022
Keyna Pidcock Skeffington General Counsel $1M Sep 15, 2022
Seng Stacy Enxing Director $725K Jun 15, 2025
Sharon O'Kane Director $705K Jun 15, 2025
Francesco Bianchi Director $697K -$148K -17.6% Aug 25, 2025
Alfred J. Novak Director $653K Jun 15, 2022
Todd C. Schermerhorn Director $602K Jun 15, 2025
Andrea Lynn Saia Director $559K Dec 31, 2023
Brooke Story Director $523K -$13.5K -2.51% Nov 18, 2025
Peter M. Wilver Director $496K Jun 15, 2025
Hugh M. Morrison Director $272K Jun 29, 2021
James Christopher Barry Director $200K Jun 15, 2025
Susan M. Podlogar Director $129K Jun 15, 2025
Donald Zurbay Director $0 Sep 15, 2025

Recent Insider Transactions by Companies or Individuals for LivaNova PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.